Astellas Pharma
FDA approves Seattle Genetics and Astellas Pharma’s bladder cancer drug
December 19, 2019Business Services Astellas Pharma, Cancer, Padcev, Seattle Genetics, bladder cancer
The FDA has granted accelerated approval for Seattle Genetics and Astellas Pharma’s bladder cancer drug Padcev (enfortumab vedotin-ejfv). The drug’s …
FDA approves Pfizer and Astellas Pharma’s prostate cancer drug
December 17, 2019Manufacturing and Production Astellas Pharma, Cancer, FDA, Pfizer, Xtandi, prostate cancer
The FDA has approved Pfizer and Astellas Pharma’s Xtandi (enzalutamide) to treat patients with a type of prostate cancer. The …
Jamie McGarvey joins Astellas Pharma communications team
September 18, 2015Medical Communications Astellas, Astellas Pharma, Jamie McGarvey
Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department. McGarvey will be …
Astellas hires Americas president
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, brian mclellan
Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. McLellan is to be …
Working Life: Mike Crooks, UK general manager, Astellas
March 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life
Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …
Astellas Pharma Europe appoints Mike Crooks to head up its UK operations
January 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks
Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
